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Biocompatibility of a Lab-on-a-Pill Sensor in
Artificial Gastrointestinal Environments
Erik A. Johannessen, Lei Wang, Cathy Wyse, David R. S. Cumming, Member, IEEE, and Jon M. Cooper*
Abstract—In this paper, we present a radiotelemetry sensor, de-
signed as a lab-in-a-pill, which incorporates a two-channel micro-
fabricated sensor platform for real-time measurements of temper-
ature and pH. These two parameters have potential application for
use in remote biological sensing (for example they may be used as
markers that reflect the physiological environment or as indica-
tors for disease, within the gastrointestinal tract). We have investi-
gated the effects of biofouling on these sensors, by exploring their
response time and sensitivity in a model in vitro gastrointestinal
system. The artificial gastric and intestinal solutions used represent
a model both for fasting, as well as for the ingestion of food and sub-
sequent digestion to gastrointestinal chyme. The results showed a
decrease in pH sensitivity after exposure of the sensors for 3 h. The
response time also increased from an initial measurement time of
10 s in pure GI juice, to ca. 25 s following the ingestion of food and
80 s in simulated chyme. These in vitro results indicate that changes
in viscosity in our model gastrointestinal system had a pronounced
effect on the unmodified sensor.
Index Terms—Biofouling, in vitro measurements, lab-in-a-pill,
microfabricated sensors, radio telemetry.
I. INTRODUCTION
THE human gastrointestinal (GI) tract is relatively inacces-sible to being probed with diagnostic sensors. This has re-
sulted in a restricted knowledge of the causes, diagnosis and
treatment of many GI diseases. Two important physico-chem-
ical parameters that can provide useful information in clinical
management of disease within the gut are those of temperature
and pH. For example, GI temperature is not only a good indi-
cator for the body core temperature [1], but local changes have
also been shown to be associated with ulcers and tissue inflam-
mation [2]. Likewise, pH can be used to identify pathological
states associated with abnormal pH levels from the oesophagus
to the distal colon, particularly those associated with pancre-
atic disease [3], portal hypertension [4], cystic fibrosis [5] and
inflammatory bowel disease [6]–[9] as well as conditions in-
volving gut interaction with host bacteria [10], [11]. In this latter
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respect, the activity of the predominant anaerobic flora alters the
pH at the distal part of the GI tract, and it is therefore believed
that this can be used as a diagnostic marker in assessing the func-
tion of the microbial population [12], [13]. Changes in local pH
have also been shown to be associated with irritable bowel syn-
drome, rheumatoid arthritis [14], ankylosing spondylitis [15]
and allergic airway disease [16].
The sensitivity and reproducibility of the diagnostic sensors
will have a direct effect on their efficacy, and consequently on
their ability to assess disease conditions. Measurements per-
formed in biological environments, including those in the GI
tract, will always be accompanied by effects associated with bio-
fouling. To date, the majority of data on the biofouling of sensors
have traditionally been studied in environmental monitoring of
wastewater [17], marine environments [18], and implantations
in vivo [19], with much less data available from measurements
associated with the gut.
In this paper we present a novel telemetry sensor, designed as
a lab-in-a-pill (LIAP), incorporating a dual channel microfabri-
cated sensor and a custom made application specific integrated
circuit (ASIC). The device was designed to enable non-inva-
sive assessment of temperature and pH in the entire gut, and
as a consequence, the ASIC included a power saving feature
for extended service lifetime. The sensor platform was devel-
oped using standard CMOS and microfabrication technologies
[20]–[22].
In this paper, the effects of biofouling are studied in three
different model gastrointestinal systems in vitro and data con-
cerning the response time and sensitivity are presented. In de-
tail, these involved (i) artificial gastric and intestinal juice as a
model for fasting; (ii) in a simulated environment concomitant
with the ingestion of food; (iii) in gastrointestinal chyme. Sensor
lifetime was monitored during the lifetime of the LIAP in order
to assess detrimental effects on the device associated with pro-
longed exposure to GI solutions. All studies were restricted to
the pH sensor alone, as the temperature sensor was embedded
in the chip, and was not in direct contact with the test solutions.
II. DESIGN AND FABRICATION
A. Sensors
The sensors were based on a research product with prede-
fined n-channels in a p-type bulk silicon substrate from Ecole
Superieure D’Ingenieurs en Electrotechnique et Electronique
(ESIEE, France) which were modified by post lithographic pat-
tern integration, described in more detail in prior publications
[20]. The sensor chip comprised two separate parts, one acting
as a pH ISFET with a microfabricated reference elec-
trode; the second as a temperature sensor (the n-channel of the
0018-9294/$20.00 © 2006 IEEE
2334 IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 53, NO. 11, NOVEMBER 2006
Fig. 1. Layout plot of the 4.5 4.5mm application specific integrated circuit
control chip (left), and the associated explanatory diagram (right). MUX ADC,
and OSC (32-kHz oscillator). The large bonding pads allow repetitive use of
wire bonding for test and verification prior to integration in the LIAP.
second part comprised the silicon diode temperature sensor).
The whole chip was subsequently encapsulated by a 50-
-thick layer of polyimide (Durimide 7020, Arch Semiconductor,
Belgium) with a window enabling direct access to the pH sensor
without the use of dialysis membranes for improved response
time. The dynamic range of the ISFET was tuned such that it
could respond with a range from pH 1 to 10, with a temperature
(reference) range from 10 to 50 .
B. ASIC
The ASIC control unit (Fig. 1) was designed using conven-
tional EDA tools and fabricated as a 44-pin 20.25 sil-
icon die using a 3-V, 2-poly, 3-metal 0.6- CMOS process
by Austria Microsystems (AMS, Austria). A key advantage of
using the AMS process is the availability of well-specified ana-
logue and digital IP blocks, such as the analog-to-digital con-
verters (ADCs), operational amplifiers and standard I/O cells
used in this design. The three functional blocks were designed to
minimize size and reduce power consumption. These comprised
the sensor interface (a 6-op-amp design and a multiplexer), a
timer (with on chip circuitry using a RC relaxation oscillator
which clocked the system at 32 kHz), and a system scheduler.
A finite state machine represented the core of the system sched-
uler, which, together with a 10-bit ADC and related digital logic
allowed several tasks to be performed such as sensor cycling and
sampling.
A sleep modus and a serial bitstream data compression
algorithm were used to enhance the power saving features. The
algorithm decided when it was necessary to start a transmission
by comparing the most recent data with the previous data
during every sample interval. If the difference between the
data sets was below a predefined tolerance limit, currently
, the scheduler did not make a
transmission. The data was instead compressed and stored on
to a local buffer until the difference between samples was more
than the tolerance limit, or when the buffer were full [23]. The
system would rest at idle between transmissions. Thus, when
quiescent, the system would run at 30% of full power.
The digitized data were fed directly into a small
“on-off-keying” (OOK) AM transmitter module running at
the licence-free 433.92-MHz ISM band. The data implemented
the Manchester code, which translated combined clock and
data signals at a rate of 4 . The data transmission pad
was designed to provide up to 8 mA of output current, and as
such powered up the radio transmitter (which were normally
turned off) when the data was transmitted from the ASIC.
C. Base Station
The base station was used to capture pH and temperature
data through wireless communication from the pill. The base
station comprised a wireless interface module, a process core
module and a data presentation module. The data presentation
was achieved with a portable PC (Toshiba, Japan), the process
core through a DAQ type PCMCIA card (National Instruments,
U.S.) and the wireless interface through a miniaturized AM
receiver. In order to set up a simplex wireless communica-
tion link between the LIAP and the base station, a TX7433AM
434-MHz ISM-band ON-OFF-Keying transmitter (in the LIAP)
and a RX7433AM small superheterodyne receiver pair were
chosen with a fixed reception frequency of 433.92 MHz (RF
Solutions, U.K.). All components were battery operated. The
data processing module ran on a Matlab 6 (Mathworks, U.S.)
routine.
D. Capsule
The LIAP was assembled on a 0.8-mm double-sided PCB
forming the backbone with predefined copper tracks defining
the power supply rails, contact points for the sensors and an inte-
grated single loop antenna corresponding to 1/16 . A schematic
of the system (Fig. 2) illustrates the different components. The
sensor chip and the ASIC were connected to the front of the
PCB board, whereas a magnet (for telemetry), and a 433.92
AM transmitter (RF Solutions, U.K.) were both connected to
the opposing side. The 3-V power supply was generated from
two SR48 battery cells (Radio Spares, U.K.) with a ca-
pacity of 75 mAh, controlled by a rear mounted 7-pin 0.8-mm
pitch socket (Radio Spares, U.K.) from which the device was ac-
tivated (this latter feature was used during in vitro testing). The
two 1.5-V batteries enabled the use of three reference voltages:
positive (1.5 V), virtual ground (0 V) and negative ( ), as
was required by the ASIC. The sensors and the ASIC were con-
nected by wire bonding, whereas the two batteries were attached
to slots made in the PCB. The contact points from the batteries
were “cold soldered” using conductive glue (Chemtronics, Ken-
nesaw, GA), whereas the wires running from the batteries and
the transmitter were tin soldered onto the PCB.
The tracks and wires were cast in high strength epoxy (Radio
spares, U.K.) for protection against the encapsulation material,
whereas an inverted 2-mm high polypropylene “cup” (made
from the bottom part of a 250 centrifuge tube, VWR, U.K.)
attached by 3140 silicone rubber (Dow corning, U.S.) formed a
seal protecting the sensors. The silicone rubber also prevented
de-lamination between the sensor chip and the encapsulation
material. The assembled device was then placed in a mould of
PTFE, for encapsulation by a low viscosity epoxy resin, Araldite
2020, (Vantigo AG, Switzerland), which took 48 h to cure to a
hard chemically resistant transparent polymer. After encapsula-
tion, drilling a 3-mm hole down to the plastic cup, which was
then removed, exposed the sensors. The complete device mea-
sured 12 36 mm and weighted 8 g including the batteries.
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Fig. 2. Computer-aided design schematic illustrating the architecture of the
LIAP. The sensor chip, incorporating a dual temperature and pH sensor, is lo-
cated at the front, followed by the ASIC and batteries. The magnet and the trans-
mitter are assembled on the reverse side. The whole unit is encapsulated in epoxy
resin (Araldite 2020), with the external connector enabling powering both from
the batteries and external sources.
III. MATERIALS AND METHODS
The gastrointestinal environment is corrosive (low pH), with
abundant bio-particles from proteins to carbohydrates and fat.
Different model solutions representing the real gastrointestinal
environment have previously been created in vitro.
Generally, the timescales over which processes associated
with protein adsorption are of the order of minutes [19], and
consequently measuring the effect of biofouling over periods of
up to 3 h provided us with useful model data. The sensors were
characterized using artificial made gastric and intestinal juice
solutions as a model for fasting, with dissolved organic material
(pet-food) as a model for the ingestion of food, and a high vis-
cosity solution resembling the intestinal chyme.
A. Artificial Gastrointestinal Solutions
Gastric juice of pH 1.2 was made from 2 g sodium chloride
(NaCl), 3.2 g pepsin (800 – 2500 ) and 7 mL 37 wt%
hydrochloric acid (HCl) was made up to 1000 mL in reverse
osmosis (RO) water. Likewise, the intestinal juice of pH 6.8
were made up from 6.8 g potassium phosphate – monobasic
( ) dissolved in 250 mL RO water, 77 mL of 0.2 M
sodium hydroxide (NaOH) and 10 g pancreatin made up to
1000 mL with RO water, and adjusted to pH 6.8 with 0.2 M
HCl or 0.2 M NaOH. All chemicals and proteins were from
Sigma Aldrich (U.K.).
Gastrointestinal solutions mixed in with 5% pet-food
(Whiskas, U.K.) were used to represent partial digested food
rich in fat, protein and solids (colloids). On addition of the
pet-food, the pH of the gastric and the intestinal juice increased
from pH 1.2 and pH 6.8 to pH 3.8 and pH 7.1, respectively.
The artificial chyme, which simulated digested food normally
encountered in the stomach before the pill enters the small in-
testine, was identical to the gastric and intestinal juice, but with
the water substituted with a milkshake solution (Friji, U.K.),
containing 85% milk, skimmed milk powder, sugar, fat, cocoa
powder, maize starch, stabilizers (carragenan, guar gum). The
chemical composition of 100 mL gastric chyme was 0.2 g NaCl,
3.82 g protein, 11.7 g sugar, 1 g fat, 0.7 mL 37 wt.% HCl, and
117 mg calcium (Ca ), adjusted to pH 1.2. Likewise, 100 mL
intestinal chyme contained 0.68 g , 7.7 mL of 0.2 M
NaOH, 4.5 g protein, 11.7 g sugar, 1 g fat and 117 mg Ca ,
adjusted to pH 6.8.
B. A Model in Vitro Gastrointestinal System
All solutions were aliquoted in standard 25 mL universal
tubes in which the LIAP telemetry device was immersed.
An oscillating hot water bath (Grant, U.K.) simulated gastric
peristalsis by moving the samples at 1 Hz while maintaining
the temperature at 37 .
1) Calibration: The pH sensor was subject to a 4-point cal-
ibration routine at pH 1, 4, 7, and 10, both immediately be-
fore and after each experiment. Each calibration was repeated
three times. The pill was immersed in each buffer solution for
2 min, with the data transmitted by wireless communication.
The reading for each pH value was assigned corresponding data-
points. Similarly, the temperature sensor was also calibrated, by
immersing the pill in a phosphate buffered saline (PBS) solution
which was cooled to 8 and then heated to temperatures in the
excess of 50 .
2) In Vitro Models: In the experimental protocols, the pill
was first immersed in gastric juice for 45 min, and then directly
transferred to intestinal juice to simulate the transition from the
stomach (acidic environment) to the duodenum (neutral/alka-
line environment) for another 45 min. Three repetitions were
made of each 90-min run, for a total duration of 4.5 h. The pro-
tocol was then extended to involve a 60-min immersion in gas-
tric chyme, before being transferred to intestinal chyme for an-
other 60 min. The total duration of this run was 2 h.
IV. RESULTS
The performance and technical data of the pill is summarized
in Table I. The power consumption was 4.75 mW in the standby
modus (3.9 mW attributed to the ASIC), whereas the power in-
creased to 15.5 mW with the transmitter powered up for signal
transmission. In our case, the transmission distance of the LIAP
was maintained to 1 m from the receiving antenna and the sig-
nals from the sensors were recorded by the base-station with the
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TABLE I
SUMMARY OF THE TECHNICAL DATA AND PERFORMANCE OF THE LIAP
data collected and presented in real time. All the characteriza-
tion experiments were performed at 37 C (body temperature).
A. Calibration
The calibration data from the temperature sensor showed a
linear response throughout the dynamic range from 10 to
50 , Fig. 3(a). One degree temperature change ( ) corre-
sponds to 11.05 ( ) data-points ( ,
), indicating that the signal resolution of the tem-
perature channel corresponds to 0.091 . However, it should
be noted that the noise baseline corresponded to
(or ) such that, at 37 , the temperature reading
corresponded to - . The response time
( ) was measured to 5.2 s.
The signal from the temperature sensor could also be ex-
pected to change with the battery supply voltage [20], since
the sensor biasing circuit and thus the diode current, , was
referenced to the negative supply voltage ( ). Thus, the
signal change per hour ( ) of - , Fig. 3(b),
( , ) corresponds to
a temperature fall of 0.62 . Given the temperature de-
pendency of the pH sensor, it was decided that a compensation
routine for this signal change could readily be implemented on
chip, or later in the data processing algorithm.
The pH sensor exhibited a linear response from pH 1 to
10 (where one pH unit corresponded to 18.2 data-points
( , ), Fig. 4. The
resolution was determined to by the inherent noise
in the pH channel of the ASIC, and the response time in pure
aqueous solutions measured to 4 s. Variations in the local
Fig. 3. Temperature sensitive responses (a) from both temperature (dotted line)
and the pH channel (solid line) illustrating the inherent temperature dependency
of any solid state semiconductor device. The battery supply voltage induced
changes (b) were performed at 25 C in a pH 7 buffer solution. The pH sensor
was preconditioned in buffer for 24 h to cancel signal drift caused by the hy-
dration of the proton sensitive membrane. The notation datapoints illustrate the
RAW data acquired directly from the sensor prior to data processing.
Fig. 4. Calibration chart of the pH sensor in gastric juice illustrating the positive
increase in offset voltage due to hydration of the pH sensitive membrane, and
the reduction in sensitivity as an effect of biofouling.
molar concentration, [ ], and its effect on the electrode
potential was also explored by aliquoting KCl into the solution
(at final concentrations of 0.01, 0.1, and 1.0 to 3 M). The
linear regression analysis with [ ] denoted by variable ,
( , ) showed a sensitivity
of 20 [ ]. Since the expected change in [ ]
within the gut will not exceed 0.5 M, from pH 1 to pH 8, we can
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conclude that resolution of the pH sensor with the integrated
reference electrode should be approximate .
Being a semiconductor device, it was noted that the pH ISFET
sensor responded to temperature in a similar manner to the sil-
icon diode used for the temperature sensor [Fig. 3(a)]. The tem-
perature response of the pH sensor (
, ) corresponded to 0.3 pH units per temper-
ature change (considering a pH sensor response of 18.2 data-
points ). Thus, the output signal from a pH 7 solution
at 25 of 205 data-points, would be the equivalent of 270
data-points at 37 .
The pH sensor output also changed with the battery supply
voltage [Fig. 3(b)] giving rise to a linear drift with time of
- , ( ,
. As a consequence, the temperature dependency
resulted in a pH change of 3.6 from 25 to 37 , whereas the
supply voltage induced a pH change of 0.23 units . Thus, it
is clear that both temperature and supply voltage drift compen-
sation of the pH channel will be required in future iterations of
the device, to enable accurate measurements (this could either
be implemented on chip through a voltage regulator, or as in
this case, the data processing algorithm in the base station).
B. In Vitro Sensor Characterisation
1) Artificial Gastrointestinal Juice: The three calibration
runs (Fig. 4) were performed prior to (run 1), after 90 min
(run 2) and after 180 min (run 3) immersion in a gastroin-
testinal juice solution. The average sensitivity (measured by
recalibrating the sensor between the runs) over the measured
pH range decreased by 2.2% between run 1 and 2, and de-
creased by 5.5% between run 1 and 3. In contrast, the positive
offset recorded in the trace increased from 328.9 to 336.5 and
342.4 data-points respectively. The error bars corresponds to
, pH 1, (equiv. ) to ,
pH 4, (equiv. ) over the 20-min duration of the
calibration protocol. The slow baseline drift with time that was
observed after comparing the initial calibration (prior to run
1), with the calibration after 90 min (run 2) and 180 min (run
3), resulted in errors corresponding to , pH
1, (equiv. 0.35 pH) to , pH 10, (equiv.
).
The experimental results (Fig. 5) showed that the sensors did
respond to changing pH throughout the experiment and did re-
calibrate after each 90-min run. On average the response time of
the pH channel was measured to ca. 10 s in both the gastric and
intestinal juice (after run 1), whereas the response time after run
2 had increased to 11.5 s in the gastric juice and 16 s in the in-
testinal juice. The recorded pH was 1.18 and 6.75 in the gastric
and intestinal juice (run 1), and 1.26 and 6. 45 in the gastric and
intestinal juice of run 2.
2) Ingested Meal: Tests conducted in artificially made gastric
and intestinal juice mixed with pet-food (Fig. 6) showed that the
sensors responded to a changing pH in the two solutions, and did
recalibrate after each 90-min run. As seen with pure gastric and
intestinal juice, the sensitivity was higher before than after the
experiment. The measured values of the gastric and intestinal
solution was 3.75 and 7.3 respectively in run 1, and 3.83 and
7.1 in run 2. The decrease in sensitivity was 1.15% between
Fig. 5. Fasting model. Pill exposed to 180-min gastric (pH 1.2) and intestinal
(pH 6.8) juice solution, presented with temperature (a) and pH channel.
(b) Arrows indicate calibration runs of the pH sensor.
Fig. 6. Ingested meal model. Test sensor was exposed to 180-min artificial
gastric juice (pH 3.8) and intestinal juice (pH 7.1) mixed with catfood.
(a) The temperature and (b) the pH channel is shown. The sensor was calibrated
prior to the measurement (t = 0), and after 90 and 180 min.
calibration run 1 and 2, and a further 2.8% in calibration run
3, was consistent with the trend observed for measurements in
pure gastric and intestinal juice. The pH values obtained from
the noisy readings of the intestinal juice were averaged over the
previous 10 min. The response time from immersion in gastric
juice was 13.8 s (run 1) and 24 s (run 2). The noise masked
any measurements of the response time in the intestinal juice
solutions.
3) Artificial Chyme: Recalibrating the sensors after the tests
conducted in the artificial chyme showed that the sensitivity
had been reduced by 3.85% to 17.5 data-points after the
180-min run. Furthermore the response time of the pH sensor
were now 80 s, clearly demonstrating the significance of per-
forming measurements in more viscous solutions.
C. Longevity Tests
The pill was tested in the artificial gastrointestinal juice so-
lution over three separate runs totalling 42 h running on battery
power alone (Fig. 7). As expected, after prolonged usage, the
offset voltage of the pH channel showed a decrease with time,
which could be attributed to the falling supply voltage from
the batteries (the pH sensor output is referenced to the positive
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Fig. 7. Longevity tests and implementation of algorithm. (a) Raw data con-
verted to pH (solid line) and temperature (dotted line). Three repetitive mea-
surements were made in gastric and intestinal juice solutions (arrows), then
immersion over night in gastric juice, before heating to 37 C in intestinal
juice until batteries were exhausted. Implementation of algorithm (b) zeroing
out signal drift in the temperature channel (voltage) and both voltage and tem-
perature drift in the pH channel. The algorithm provides comprehensive data,
which are only compromised by nonlinear characteristics when the batteries are
close to exhaustion.
supply rail, VSSA, [20]). The results Fig. 7(a) show temperature
(dotted line) and pH (solid line). Throughout this period, the
pill was successively immersed between gastric and intestinal
juice (3 parallels) before resting in gastric juice until 20 h had
passed. The pill was then immersed in intestinal juice at 37
for a further 22 h. At a constant temperature of 37 , one could
clearly see the steady state drift in both sensor channels due to
the reduced supply voltage from the batteries. The experiment
continued until the batteries were exhausted. Thus, one can con-
clude that the SR48 batteries used were able to power the
pill for up to 42 h in total.
It is clear that the influence of the battery supply voltage
on the temperature channel, and the influence of both supply
voltage and temperature on the pH channel, affects the per-
formance of the system. Thus, an algorithm, based on the
supply voltage characteristics of the temperature channel, and
the supply voltage and temperature characteristics of the pH
channel, was employed in the base-station side to offset these
effects. The results Fig. 7(b) clearly illustrate how the tempera-
ture change between 16 and 20 h did not affected the pH sensor,
which at the same time measured the correct pH readings from
immersion in the gastric and intestinal juice. The drift in the
temperature channel was significantly reduced, although the
algorithm did not compensate for the non-linear characteristics
seen in the circuitry due to failing batteries towards the end of
the experiment.
V. DISCUSSION
The change in offset voltage with time of the pH sensors can
be explained by the hydration of the pH sensitive mem-
brane changing the threshold potential, , of the ISFET. The
long-term signal drift (apparent in the intestinal juice solution)
is believed to be a result from the interaction of proton reactive
sites in the bulk of the membrane [24], with the drift be-
coming more predominant in alkaline solutions and at higher
temperatures [25].
A. Artificial Gastrointestinal Juice
When compared to run 1, the delayed response from the pH
sensor can clearly be seen in run 2 upon immersion in both
gastric and intestinal juice. This effect can be attributed to bio-
fouling, since the sensors, after recalibration, showed a reduced
sensitivity. The source of biofouling was most likely absorption
of pepsin and pancreatin on the pH sensitive membrane since
this was the only organic agent present in both the gastric and
intestinal juice. The consequence from the absorption of these
proteins is that of either reducing the effective surface area of the
sensor on which the protons can absorb to (lowering the sensi-
tivity) or of generating an additional diffusion barrier through
which the protons much pass (increasing response time). Both
effects are apparent in Run 2.
In the gastric juice, the response time increased to 11.5 s
(from 10.0 s), whereas the pH reading were 0.1 units above the
recorded data from the previous run. The consequent immersion
in the intestinal juice showed that the response time had now in-
creased to 16 s, whereas the pH reading never came closer than
0.3 units below the recorded value from the previous run. One
can therefore conclude the presence of biofouling in terms of
reduced sensitivity and increased response time, although the
function of the pH sensor was not significantly affected by this
parameter.
B. Ingested Meal
The noisy recordings registered in the intestinal juice with
partial digested pet-food were believed to be an effect of large
particles (note that the sensor behaved normally upon recalibra-
tion). These particles could have generated noise by coming into
contact with the pH sensitive gate membrane in the stirred solu-
tion (in the gastric juice, these particles were not visible due to
the action of pepsin).
The observed temperature changes were a result from fluctu-
ations due to the sensor moving in the more viscous solution.
Corresponding fluctuations in the pH sensor were also apparent
(Fig. 6 shows the raw data without implementation of the tem-
perature compensation algorithm). The increased response time
of the pH sensor of 13.8 s in run 1 and 24 s in run 2, reflected the
increase in solution viscosity, but also the addition of secondary
fouling agents such as dissolved fat or fatty acids present in the
pet-food. The calibration data after removal of the sensors ex-
hibited a similar response as observed for the pure gastric and
intestinal juice experiments, thus any detrimental permanent ef-
fects from biofouling were considered as small.
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C. Chyme
The main change in characteristic associated with measure-
ments performed in the artificial chyme was the increased re-
sponse time of the sensor to 80 s compared to the measurements
from pure GI juice or juice mixed with pet-food. The increased
viscosity of the solution provided a residual layer on the surface
of the sensor, through which analyte has to diffuse. Cleaning
the sensors removed this residual layer and subsequent recali-
bration showed that the response time were comparable to that
in pure aqueous solutions ( ). Thus, allowances had to be
made for a comparable delay in the real in vivo experiments.
Considering an average passage speed of 0.3 in the
small intestine [26], the capsule would have travelled 28 mm
down the intestinal tract before the sensor would respond to the
signal. Thus, a careful redesign by positioning the sensor much
closer to the capsule surface could improve the response time in
viscous solutions.
VI. CONCLUSION
Results showed that the sensitivity of the pH channel de-
creased between 3.8% and 5.5% during measurements of up to
180 min. The response time of the sensor increased from an ini-
tial 10 s in pure GI juice to 11.5 s in pure gastric juice and 16 s
in pure intestinal juice respectively. Exposure to GI solutions
mixed with 5% food increased the time from 13.8 s to 24 s,
whereas the response time was measured to 80 s in simulated
chyme. The in vitro results suggest that the biofouling on naked
solid state silicon sensors did not significantly affect the data
over the 3-h controlled measurement periods, and that the sen-
sors would operate for a 42-h lifetime of the device. The data
acquired with the increasing viscosity of the solutions, showed
that measurements performed synchronous with the ingestion of
food could be affected by the increased response time. In con-
text, considering the slow passage speed in the gut, signals could
still be detected within an accuracy of 30 mm in the small in-
testine. Thus, the potential of radiotelemetric chemical imaging
would allow for screening of disease conditions without the re-
quirement of visual aids.
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